Catalyst Wire Dossier Catalyst Wire Dossier

Moventig

naloxegol oxalate · Grunenthal GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Moventig, covering 2025-04-11 to 2025-04-11. Get the full timeline:

Most recent: EMA Authorised: Moventig (naloxegol oxalate) — Grunenthal GmbH

See pricing